AB 2664 Supports Innovation, Entrepreneurship at UC
A $22 million investment via California State Assembly Bill 2664 is supporting innovation and entrepreneurship at UC San Francisco and across the University of California system.
University of California San Francisco
Give to UCSF
Precision-Medicine Approach Could Revive Prostate Cancer Test
A new study identified genetic predictors of normal prostate-specific antigen (PSA) levels in healthy men, which could be used to improve the accuracy of PSA-based prostate cancer screening tests.
New ‘Immunoprofiler’ Initiative will Advance Drug Discovery, Precision Immunotherapy for Cancer
UC San Francisco scientists have formed an innovative research alliance with three global pharmaceutical companies.
UCSF, Intel Join Forces to Develop Deep Learning Analytics for Health Care
UC San Francisco’s Center for Digital Health Innovation announced a collaboration with Intel Corporation to deploy and validate a deep learning analytics platform designed to improve care.
UCSF, Pfizer Renew Research Collaboration, Citing Progress in Drug Discovery Research
UC San Francisco and Pfizer Inc.’s Centers for Therapeutic Innovation have renewed an agreement to identify and develop biologic compounds against both known and novel targets.
Off-Switch for CRISPR-Cas9 Gene Editing System Discovered
UCSF researchers have discovered a way to switch off the widely used CRISPR-Cas9 gene-editing system using newly identified anti-CRISPR proteins that are produced by bacterial viruses.
UCSF Joins Multi-University Collaboration Agreement with Facebook’s Building 8
UCSF is joining a unique collaboration agreement with Facebook that would allow its researchers to engage in joint technology projects without the usual red tape.
CRISPR Study Reveals Unexpected Roles of Non-Coding RNAs
UCSF researchers have taken a major step toward understanding the function of the tens of thousands of human genes that do not code for proteins, a phenomenon considered one of the key remaining mysteries of the human genome.
CRISPR-Based Single-Cell Genetics Platform Enables Rapid Analysis of Critical Gene Networks
Researchers from UC San Francisco and the Broad Institute of MIT and Harvard have developed a new method for performing high-throughput functional screening of complex genetic interactions.
New Targeted Chemotherapy Technology Proves Effective in Mice
UCSF researchers have developed a new variety of targeting system for chemotherapy drugs based on the unusually high free iron content of many cancer cells.
UCSF, GE Healthcare Launch Deep Learning Partnership to Advance Care Globally
UCSF’s Center for Digital Health Innovation and GE Healthcare today announced a partnership to develop a library of deep learning algorithms.
FDA Funds UCSF-Stanford Center on Regulatory Science
The U.S. Food and Drug Administration has awarded the UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (UCSF-Stanford CERSI) a five-year grant with up to $25 million in funding.
As Smartphone Use Increases, So Does Lack of Sleep
Smartphone use directly correlates with sleep, with greater use demonstrating a significant association with shorter sleep duration and worse sleep efficiency, according to researchers at UCSF.
Researchers Use CRISPR to Accelerate Search for HIV Cure
Researchers at UCSF and the academically affiliated Gladstone Institutes have used a newly developed gene-editing system to find gene mutations that make human immune cells resistant to HIV infection.
NSF Funds ‘Blue Sky’ Bioengineering Center To Be Based at UCSF
The National Science Foundation has awarded $24 million over five years for a new ‘blue-sky’ bioengineering center based at UCSF.